On this page of StockholderLetter.com we present the latest annual shareholder letter from Eightco Holdings Inc. — ticker symbol OCTO. Reading current and past OCTO letters to shareholders can bring important insights into the investment thesis.
EIGHTCO HOLDINGS INC. 2024 ANNUAL REPORT Eightco Holdings Inc. Board of Directors and Executive Officers as of December 1, 2025 BOARD OF DIRECTORS Name Principal Occupation or Employment Daniel Ives Managing Director, Senior Equity Research Analyst, and Global Head of Technology Research at Wedbush Securities Chief Executive Officer of Eightco Holdings Inc. President of Pelago Health Chief Executive Officer of Enventys Chief Financial Officer of Cytometric Therapeutics Kevin O Donnell Frank Jennings Louis Foreman Nicola Caiano EXECUTIVE OFFICERS Name Principal Occupation or Employment Kevin O Donnell Brett Vroman Chief Executive Officer Chief Financial Officer This Annual Report contains forward-looking statements. All statements contained in this Annual Report other than statements of historical fact, including statements regarding our future results of operations and financial position, our business strategy and plans, and our objectives for future operations, are forward-looking statements. Please read the section of our Annual Report on Form 10-K entitled Cautionary Note Regarding Forward-Looking Statements for a discussion of the limitations and risks regarding forward-looking statements made in this Annual Report. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including those described in Part I, Item 1A, Risk Factors of our Annual Report on Form 10-K included herein, which may cause actual results to differ materially from those contained in any forwardlooking statements we may make. We undertake no obligation to revise or publicly release the results of any revision to these forward-looking statements, except as required by law. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements.
 • shareholder letter icon 12/1/2025 Letter Continued (Full PDF)
 • stockholder letter icon 11/6/2023 OCTO Stockholder Letter
 • Benford's Law Stocks icon OCTO Benford's Law Stock Score = 100


OCTO Shareholder/Stockholder Letter Transcript:

EIGHTCO HOLDINGS INC. 2024 ANNUAL REPORT
Eightco Holdings Inc. Board of Directors and Executive Officers as of December 1, 2025
BOARD OF DIRECTORS
Name
Principal Occupation or Employment
Daniel Ives
Managing Director, Senior Equity Research Analyst, and Global Head of
Technology Research at Wedbush Securities
Chief Executive Officer of Eightco Holdings Inc.
President of Pelago Health
Chief Executive Officer of Enventys
Chief Financial Officer of Cytometric Therapeutics
Kevin O   Donnell
Frank Jennings
Louis Foreman
Nicola Caiano
EXECUTIVE OFFICERS
Name
Principal Occupation or Employment
Kevin O   Donnell
Brett Vroman
Chief Executive Officer
Chief Financial Officer
This Annual Report contains forward-looking statements. All statements contained in this Annual Report other than statements
of historical fact, including statements regarding our future results of operations and financial position, our business strategy
and plans, and our objectives for future operations, are forward-looking statements. Please read the section of our Annual
Report on Form 10-K entitled    Cautionary Note Regarding Forward-Looking Statements    for a discussion of the limitations
and risks regarding forward-looking statements made in this Annual Report. These forward-looking statements are subject to
a number of risks, uncertainties and assumptions, including those described in Part I, Item 1A,    Risk Factors    of our Annual
Report on Form 10-K included herein, which may cause actual results to differ materially from those contained in any forwardlooking statements we may make. We undertake no obligation to revise or publicly release the results of any revision to these
forward-looking statements, except as required by law. Given these risks and uncertainties, readers are cautioned not to place
undue reliance on such forward-looking statements.


shareholder letter icon 12/1/2025 Letter Continued (Full PDF)
 

OCTO Stockholder/Shareholder Letter (Eightco Holdings Inc.) | www.StockholderLetter.com
Copyright © 2023 - 2026, All Rights Reserved

Nothing in StockholderLetter.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy.